Business Description
Medartis Holding AG
ISIN : CH0386200239
Share Class Description:
FRA:1RU: Ordinary SharesTotal Employee Number:
1,337Description
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.21 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.57 | |||||
Debt-to-EBITDA | 3.45 | |||||
Interest Coverage | 0.26 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.21 | |||||
Beneish M-Score | -2.11 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.9 | |||||
3-Year EBITDA Growth Rate | 54.9 | |||||
3-Year Book Growth Rate | 3.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 84.33 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 18.97 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 40.69 | |||||
9-Day RSI | 52.67 | |||||
14-Day RSI | 56.97 | |||||
3-1 Month Momentum % | -6.9 | |||||
6-1 Month Momentum % | -14.56 | |||||
12-1 Month Momentum % | -8.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.21 | |||||
Quick Ratio | 1.1 | |||||
Cash Ratio | 0.37 | |||||
Days Inventory | 495.09 | |||||
Days Sales Outstanding | 62.29 | |||||
Days Payable | 63.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.6 | |||||
Shareholder Yield % | -1.82 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 75.89 | |||||
Operating Margin % | 0.72 | |||||
Net Margin % | 3.1 | |||||
EBITDA Margin % | 16.98 | |||||
FCF Margin % | 3.48 | |||||
OCF Margin % | 12.94 | |||||
ROE % | 3.1 | |||||
ROA % | 1.69 | |||||
ROIC % | 0.38 | |||||
3-Year ROIIC % | 1.44 | |||||
ROC (Joel Greenblatt) % | 11.85 | |||||
ROCE % | 4.69 | |||||
Years of Profitability over Past 10-Year | 8 | |||||
Moat Score | 4 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 134.67 | |||||
Forward PE Ratio | 60.74 | |||||
PE Ratio without NRI | 184.14 | |||||
Shiller PE Ratio | 450.76 | |||||
Price-to-Owner-Earnings | 29.79 | |||||
PEG Ratio | 8.37 | |||||
PS Ratio | 4.17 | |||||
PB Ratio | 4.07 | |||||
Price-to-Tangible-Book | 31.21 | |||||
Price-to-Free-Cash-Flow | 120.3 | |||||
Price-to-Operating-Cash-Flow | 32.28 | |||||
EV-to-EBIT | 61.06 | |||||
EV-to-EBITDA | 27.07 | |||||
EV-to-Revenue | 4.6 | |||||
EV-to-FCF | 134.86 | |||||
Price-to-GF-Value | 0.8 | |||||
Price-to-Projected-FCF | 4.51 | |||||
Price-to-Peter-Lynch-Fair-Value | 8.03 | |||||
Price-to-Graham-Number | 15.66 | |||||
Earnings Yield (Greenblatt) % | 1.63 | |||||
FCF Yield % | 0.83 | |||||
Forward Rate of Return (Yacktman) % | 20.27 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medartis Holding AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 287.874 | ||
| EPS (TTM) (€) | 0.719 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 26.84 | ||
| 14-Day RSI | 56.97 | ||
| 14-Day ATR (€) | 1.787963 | ||
| 20-Day SMA (€) | 90.225 | ||
| 12-1 Month Momentum % | -8.06 | ||
| 52-Week Range (€) | 77.5 - 104.8 | ||
| Shares Outstanding (Mil) | 12.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medartis Holding AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medartis Holding AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2026 | 2026-08-19 09:30 | In 33 days | ||
| Second quarter earnings results for 2026 | 2026-08-19 07:00 | In 33 days | ||
| General meeting for 2026 | 2026-04-23 10:00 | 85.50 (-0.58%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-17 10:30 | 91.40 (+1.90%) | ||
| Annual report for 2025 | 2026-03-17 | 91.40 (+1.90%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-17 | 91.40 (+1.90%) | ||
| Second quarter earnings conference call for 2025 | 2025-08-19 09:30 | 79.40 (+2.45%) | ||
| Second quarter earnings results for 2025 | 2025-08-19 07:00 | 79.40 (+2.45%) | ||
| General meeting for 2025 | 2025-04-25 | -- | ||
| Fourth quarter earnings conference call for 2024 | 2025-03-18 10:30 | -- |
Show
Entries
Medartis Holding AG Frequently Asked Questions
What is Medartis Holding AG(FRA:1RU)'s stock price today?
The current price of FRA:1RU is €93.00. The 52 week high of FRA:1RU is €104.80 and 52 week low is €77.50.
When is next earnings date of Medartis Holding AG(FRA:1RU)?
The next earnings date of Medartis Holding AG(FRA:1RU) is 2026-08-19 Est..
Does Medartis Holding AG(FRA:1RU) pay dividends? If so, how much?
Medartis Holding AG(FRA:1RU) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Medartis Holding AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers